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Conclusion: Carotid stenting in the eldedy population can be done with a markedly low 
incidence of strokes and death. These data also suggest that there is a strong trend with 
NP to reducing minor neurological events. 
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Stephen R. Ramee. Robert Dawson, Robert Felbe~g, Kevin L. McKinley, Tyrone L. 
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Foundation, New Orleans, Louisiana. 
Background: Symptomatic intracranial atherosclerosis has a poor prognosis and current 
medical therapies are often ineffective. Drawing from our experience with coronary inter- 
vention, we theorized that a catheter-based approach could be safe and beneficial in this 
patient population. 
Methods: We retrospectively reviewed the results from all patients undergoing elective 
intrecranial intervention between 4/97-5/01. The muitldisciplinary team included a neuro- 
radiolgist and an interventional cardiologist, and all patients were evaluated pra- and 
pest-procedure by a stroke neurologist. Provisional stenting was performed for complex 
lesion morphology or a suboptimal balloon result. 
Results: Twenty patients (mean age 67, range 45-87 years) were referred for interven- 
tion with intrecranial internal carotid (75%) or vertebrobasilar stenosis (25%). Symptoms 
included TIA (40%), stroke (35%), or both (25%). Ten patients (50%) received balloon 
angioplasfy and 10 (50%) received stents. Coronary equipment was used in all cases. 
The indication for stenting was complex lesion morphology in 7 (70%), and suboptimal 
balloon result in 3 (30%). Procedural and in-hospital success was 100%. There were no 
TIAs or strokes. At 30 days, all patients were alive and 95% had symptomatic improve- 
ment. At last follow-up (mean 12.7, range 2-45 months), symptomatic improvement per- 
sisted in 90% of patients. One late death occurred in a patient with multi-organ failure. 
Fifty percent of our patients had an "unexpected benefit" from the procedure, defined as 
improvement in a chronic neurologic deficit thought to be permanent. 
Conclusion: Intracranial angloplasfy with provisional stenting is both safe and beneficial 
to the majorify of patients in this study with symptomatic intrecranial stenosis. A multldis- 
ciplinary team is the ideal way to manage these patients. Our single center results justify 
a larger controlled prospective tdal to further define who will benefit from this type of 
treatment. 
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To prevent distal embolization during carotid artery stenting (CAS), a variefy of protection 
systems is presently under clinical investigation. Their efficacy needs yet to be estab- 
lished. Methods: In a pilot study, 21 consecutive patients (8 f, 13 m; 68.6 ± 8.5 years) 
underwent diffusion-weighted magnetic resonance imaging (DWMRI) pra and within 24 
hours post elective CAS. Filter-based protection systems were used in 20 patients: Neu- 
roShield (MedNova, n = 10), TRAP (Microvena, n = 4), AngloGuard (Cordis, n = 2), Filter- 
Wire (Boston Scientific, n = 2), and Distal Protection Device (Medtronic AVE, n = 2). In 
the remaining patient, an =endovascular clamping" device (MO.MA, Invatec) was 
employed which enables balloon occlusion of both external and common carotid artery 
prior to treatment of an internal carotid artery lesion. Results: All CAS procedures were 
successfully completed, with the protection devices used as intended. On preinterven- 
tional DWMRI, no patient exhibited signs of recent cerebral ischemia. Postprocedura, 1 
patient experienced transient narrowing of the visual field indicative of retinal ischemia, 
An anatomical correlate was not detected on DWMRI. However, new ischemic foci were 
detected in the cerebral territory supplied by the targeted carotid artery in another 5 
patients (23.8%) who expedencad no clinical sequelae. The protection systems which 
had been in use in these patients were TRAP (n = 2), NeuroShield (n = 1), FiiterWira (n = 
t) and MO.MA (n = 1). Conclusion: Despite protection, clinically silent tocal cerebral 
ischemia is observed in about 25% of CAS procedures. Its etiology remains to be estab- 
lished, and there seems to be no predilection of the type of protection system used. Fur- 
ther investigation is warranted. 
1197-9 Stent  Suppor ted  Carot id  Ar tery  Angloplasty: The Impact  
o f  Renal  Function on the Neuro log ica l  Outcome 
Luis Grubaro, John R. Laird, Jr., Lowell F. Satler, Bryan H. Curry, Lee H. Monsein, Dancia 
Langley, Regina Deible, Ellen E. Pinnow, Joseph Lindsey, Jr., Washington Hospital 
Center, Washington, DisL of Columbia, Rambam Medical Center, Haifa, Israel. 
Background: Stent supported carotid artery angioplasty (SSCA) is increasingly gaining 
acceptance as an aitemative to surgical endarteractomy for the treatment of carotid 
artery stenosis. The impact of chronic renal insufficiency (CRI) on the outcome after this 
procedure is unknown, Methods: A total of 248 consecutive patients underwent 253 pro- 
cedures at our institution. We analyzed the clinical outcome according to calculated craa- 
tinine clearance (CrCI). Normal CrCI (>70 mlJmin) n=93; mild CRI (CRC1=50-69 mL/min) 
n=78; and severe CRI (CrCI<50 mL/min) n=77. Results: Patients with lower CrCI war 
older, more frequently female and had a higher incidence of diabetes. Procedural suc- 
cess was >99% for all three groups. The 30-day neurological complications are shown in 
the Table, Four out of eight patients who had a major stroke had a CrCI <30 mL/min, 
Conclusions: 1) Patients with even mild CRI demonstrated an overwhelmingly high rate 
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of neurological complications. 2) Patients with severe CRI are at a higher risk for major 
neurological complications. 3) New approaches, such as distal protection devices, may 
Age (years) 68 72 76 0.001 
Major stroke 1 (1%) 2 (2.6%) 5 (6.5%) 0.13 
Minor stroke 4 (4.3%) 4 (5.1%) 7 (9.1%) 0.13 
Ipsilateral 4 3 7 0.29 
Contralateral 0 1% 0 0.33 
Permanent 0 0 1% 0.33 
Transient 4 % 3 % 6 % 0.48 
TIA 0 3 (3.9%) 1 (1.3%) 0.13 
Fatal stroke O 0 2 (2.6%) 0.11 
Total neurological events 5 (5.4%) 9 (11.5%) 13 (16.9%) 0.05 
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Background: Despite its effectiveness in acute stroke, intravenous thrombolysis (lysis) 
is used in < 3% of acute strokes. Pts who do not qualify may benefit from a catheter- 
based (CS) approach. 
Methods: We retrospectively reviewed the outcome of all pts with acute stroke ineligible 
for intravenous lysis and referred for CB intervention between 4/96 and 7/01. 
Results: 17 pts (age 35-85 yrs, 65% male) with acute stroke ineligible for intravenous 
lysis were referred for emergent CB intervention by a multidisciplinary stroke team neu- 
rologist. A culprit lesion was identified in 14 of 17 pts (82%). Treatment was initiated at a 
median of 198 rots (40 rots - 5 days) from symptom onset: lysis (5) ; balloon engioplasty/ 
stenting (3); combined lysis and rescue angioplasty (5); systemic anticoagulation (1); no 
culprit lesion - only oral antiplatelet herapy (3). 
NIH stroke scale (NIHSS) and modified Rankin score improved significantly at 30 days 
(table); Wilcoxin score p=0.0005 for NIHSS and p = 0,002 for modified Rankin score. 4 
pts (24%) died within 30 days: 2 (12%) of intrecranial hemorrhage and 2 of non-neuro- 
logic causes. 30 day survival was 76% and excellent outcome with modified Rankin 
score of _< 1 was achieved in 59%. 
Conclusions: Based on this single center experience, CB intervention for acute stroke 
appears safe and feasible with a good clinical outcome among patients ineligible for 
intravenous lysis. Further study for the role of CB therapy in acute ischemic stroke com- 
pared to best medical therapy is warranted. 
Baseline 30 day P value 
NIHSS (0-42) 10.0 ± 5.2 3.3 ± 5,5 0,003 
Modified Rankin Score (0-5) 3.1 ± 1.0 1.4 ± 1.5 0.003 
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Background: Complications of carotid aogioplasty usually occur due to embolization of 
arteriosclerotic debris. Reversal of blood flow in the internal carotid artery during anglo- 
plasty and stanting has been suggested to prevent this. 
Patients: Carotid angioplasty and stenting under flow reversal was attempted in 18 
patients (age 66 ± 10). 8 patients had a previous ipsilataral TIA and or stroke. Diameter 
stenosis ranged from 60 to 95 % (77 :t: 10), the length of the lesion ranged from 5 to 25 
mm. At least one lesion contained fresh thrombus. One patient had a contralateral steno- 
sis of > 50% and one patient had a contralataral occlusion. 
Methods: Reversal of blood flow in the internal carotid artery was achieved by occlusion 
of both the common and the external carotid artery during the procedure using the Arte- 
da TM device. During the procedure the blood flowing back into the guiding catheter was 
re-transfused into the femoral vein via a filter. Conventional wires and balloons where 
used. A Wallstent was implanted in all patients. 
Results: The device could easily be introduced into the common carotid artery. Balloon 
occlusion of the common carotid artery as well as the external carotid artery was 
achieved in all patients. The occlusion time ranged between 6 and 37 rain (16 ± 10) and 
was tolerated reasonable in all patients except one, in whom the balloon had to be 
deflated repeatedly during the procedure. Two patients experienced transient neurologi- 
cal symptoms during balloon occlusion without need for interruption of the procedure, In 
all patients angiographic was achieved without immediate complications. In one patient a 
TIA occurred several hours later. Macroscopic debris was found in the filter in 17/18 
patients. 
Conclualona: Flow reversal in the carotid artery for protection of embolism during 
carotid angioplasty is feasible in the majority of patients. Atherosclerotic debris is kept 
back efficiently. If the balloon occlusion is not tolerated, the procedure can be completed 
by deflating the balloon intermittently. As in any other embolic protection device, late 
ischemic events can not be avoided. 
be warranted in this high-risk population. 
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